deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01958944

Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis

Phase II Prospective, Open Labeled, Multi-Center, Evaluation of the Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Cystic Fibrosis

Sponsor: Beyond Air Inc.

Conditions Cystic Fibrosis
Interventions Nitric oxide
Updated 8 times since 2017 Last updated: Jun 2, 2016 Started: Dec 31, 2013 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Cystic Fibrosis, this trial is completed. The trial is conducted by Beyond Air Inc. and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotCompleted~Sep 2019 – ~Nov 2020 · 14 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

▶ Show 3 earlier versions

  1. Sep 2019 — Nov 2020 [monthly]

    Completed PHASE1_PHASE2

  2. Jun 2018 — Sep 2019 [monthly]

    Completed PHASE1_PHASE2

  3. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beyond Air Inc.
  • Schneider Children's Medical Center, Israel
  • Soroka University Medical Center
Data source: Beyond Air Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations